nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—ABCG2—Dactinomycin—ocular cancer	0.328	0.414	CbGbCtD
Sulfasalazine—ABCC2—Carboplatin—ocular cancer	0.244	0.308	CbGbCtD
Sulfasalazine—ABCG2—Carboplatin—ocular cancer	0.221	0.278	CbGbCtD
Sulfasalazine—CHUK—Signaling by NGF—MDM2—ocular cancer	0.000152	0.000733	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—GNAQ—ocular cancer	0.00015	0.000723	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SAG—ocular cancer	0.000149	0.000721	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—MYC—ocular cancer	0.000147	0.000711	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—MAML2—ocular cancer	0.000147	0.000709	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—TGFB1—ocular cancer	0.000147	0.000709	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by SCF-KIT—HRAS—ocular cancer	0.000147	0.000708	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000147	0.000707	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000146	0.000705	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—E2F5—ocular cancer	0.000146	0.000704	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.000145	0.000701	CbGpPWpGaD
Sulfasalazine—CHUK—BDNF signaling pathway—HRAS—ocular cancer	0.000144	0.000696	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—TGFB1—ocular cancer	0.000144	0.000694	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—E2F4—ocular cancer	0.000143	0.000689	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—CDK4—ocular cancer	0.000141	0.00068	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling of activated FGFR—HRAS—ocular cancer	0.00014	0.000677	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—RBL1—ocular cancer	0.00014	0.000676	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—SAG—ocular cancer	0.000139	0.000673	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—CDKN1B—ocular cancer	0.000139	0.000669	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB4—HRAS—ocular cancer	0.000138	0.000667	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—MDM2—ocular cancer	0.000138	0.000664	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—EP300—ocular cancer	0.000137	0.000663	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—MDM2—ocular cancer	0.000136	0.000654	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—E2F5—ocular cancer	0.000132	0.000638	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—HRAS—ocular cancer	0.000132	0.000637	CbGpPWpGaD
Sulfasalazine—PTGS2—C-MYB transcription factor network—HRAS—ocular cancer	0.000132	0.000635	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—HRAS—ocular cancer	0.000131	0.000634	CbGpPWpGaD
Sulfasalazine—CHUK—Regulation of toll-like receptor signaling pathway—AKT1—ocular cancer	0.000131	0.000632	CbGpPWpGaD
Sulfasalazine—IKBKB—BDNF signaling pathway—HRAS—ocular cancer	0.000131	0.000631	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—HRAS—ocular cancer	0.000131	0.000631	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—HRAS—ocular cancer	0.00013	0.000627	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by SCF-KIT—AKT1—ocular cancer	0.00013	0.000625	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—E2F4—ocular cancer	0.00013	0.000625	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—ocular cancer	0.000128	0.000618	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MAML2—ocular cancer	0.000128	0.000618	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—CDKN1A—ocular cancer	0.000128	0.000617	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—MYC—ocular cancer	0.000128	0.000616	CbGpPWpGaD
Sulfasalazine—CHUK—BDNF signaling pathway—AKT1—ocular cancer	0.000127	0.000615	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TGFB1—ocular cancer	0.000127	0.000614	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—RBL1—ocular cancer	0.000127	0.000613	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—CDKN1B—ocular cancer	0.000126	0.000607	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000124	0.0006	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling of activated FGFR—AKT1—ocular cancer	0.000124	0.000598	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—CDKN1B—ocular cancer	0.000124	0.000597	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—E2F5—ocular cancer	0.000123	0.000595	CbGpPWpGaD
Sulfasalazine—PPARG—Circadian rythm related genes—TP53—ocular cancer	0.000123	0.000594	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.000123	0.000592	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—ocular cancer	0.000122	0.00059	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—HRAS—ocular cancer	0.000122	0.00059	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—HRAS—ocular cancer	0.000122	0.00059	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB4—AKT1—ocular cancer	0.000122	0.000589	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—E2F3—ocular cancer	0.000122	0.000586	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—HRAS—ocular cancer	0.000121	0.000585	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—TP53—ocular cancer	0.000121	0.000584	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000121	0.000583	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—E2F4—ocular cancer	0.000121	0.000583	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.00012	0.000581	CbGpPWpGaD
Sulfasalazine—IKBKB—Insulin Signaling—HRAS—ocular cancer	0.00012	0.00058	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—HRAS—ocular cancer	0.00012	0.00058	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—HRAS—ocular cancer	0.00012	0.000577	CbGpPWpGaD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—ocular cancer	0.000119	0.000573	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—RBL1—ocular cancer	0.000119	0.000572	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—RPL39—ocular cancer	0.000119	0.000572	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—TP53—ocular cancer	0.000118	0.000571	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—AKT1—ocular cancer	0.000117	0.000562	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—ocular cancer	0.000116	0.000561	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—CDKN1A—ocular cancer	0.000116	0.00056	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—AKT1—ocular cancer	0.000116	0.000559	CbGpPWpGaD
Sulfasalazine—IKBKB—BDNF signaling pathway—AKT1—ocular cancer	0.000116	0.000557	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—AKT1—ocular cancer	0.000115	0.000557	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—AKT1—ocular cancer	0.000115	0.000554	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—CDKN1A—ocular cancer	0.000114	0.000551	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000113	0.000547	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—HRAS—ocular cancer	0.000113	0.000546	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—HRAS—ocular cancer	0.000113	0.000546	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—ocular cancer	0.000113	0.000546	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TFDP1—ocular cancer	0.000113	0.000545	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—ocular cancer	0.000111	0.000535	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—E2F3—ocular cancer	0.00011	0.000532	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—EP300—ocular cancer	0.000109	0.000524	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	0.000108	0.000523	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000108	0.000522	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	0.000108	0.000521	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—AKT1—ocular cancer	0.000108	0.000521	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—AKT1—ocular cancer	0.000108	0.000521	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—HDAC1—ocular cancer	0.000107	0.000519	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—AKT1—ocular cancer	0.000107	0.000517	CbGpPWpGaD
Sulfasalazine—IKBKB—Insulin Signaling—AKT1—ocular cancer	0.000106	0.000512	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—AKT1—ocular cancer	0.000106	0.000512	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—AKT1—ocular cancer	0.000106	0.00051	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TP53—ocular cancer	0.000105	0.000506	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000105	0.000505	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—EP300—ocular cancer	0.000104	0.000502	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—HRAS—ocular cancer	0.000103	0.000495	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—ocular cancer	0.000103	0.000495	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TFDP1—ocular cancer	0.000102	0.000494	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—AKT1—ocular cancer	0.000102	0.000493	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000102	0.00049	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—AKT1—ocular cancer	0.0001	0.000482	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—AKT1—ocular cancer	0.0001	0.000482	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—GNA11—ocular cancer	9.97e-05	0.000481	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	9.96e-05	0.000481	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	9.8e-05	0.000473	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—CDKN2B—ocular cancer	9.64e-05	0.000465	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	9.57e-05	0.000462	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TFDP1—ocular cancer	9.56e-05	0.000461	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—MYC—ocular cancer	9.47e-05	0.000457	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—TGFB1—ocular cancer	9.45e-05	0.000456	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—HDAC1—ocular cancer	9.37e-05	0.000452	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—GNAQ—ocular cancer	9.27e-05	0.000447	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—EP300—ocular cancer	9.1e-05	0.000439	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—AKT1—ocular cancer	9.07e-05	0.000437	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MAML2—ocular cancer	8.97e-05	0.000433	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	8.68e-05	0.000419	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—MDM2—ocular cancer	8.66e-05	0.000418	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	8.66e-05	0.000418	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—HRAS—ocular cancer	8.48e-05	0.000409	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CDKN2B—ocular cancer	8.4e-05	0.000405	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—EP300—ocular cancer	8.38e-05	0.000404	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—HRAS—ocular cancer	8.34e-05	0.000402	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—MDM2—ocular cancer	8.32e-05	0.000401	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—AKT1—ocular cancer	8.3e-05	0.0004	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MAML2—ocular cancer	8.14e-05	0.000393	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CDKN1B—ocular cancer	7.91e-05	0.000382	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—MDM2—ocular cancer	7.86e-05	0.000379	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—GNA11—ocular cancer	7.85e-05	0.000379	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—GNA11—ocular cancer	7.83e-05	0.000378	CbGpPWpGaD
Sulfasalazine—PPARG—Generic Transcription Pathway—MYC—ocular cancer	7.76e-05	0.000374	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—HRAS—ocular cancer	7.69e-05	0.000371	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CDKN1B—ocular cancer	7.6e-05	0.000366	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—EP300—ocular cancer	7.59e-05	0.000366	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MAML2—ocular cancer	7.59e-05	0.000366	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—HRAS—ocular cancer	7.56e-05	0.000365	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—MDM2—ocular cancer	7.54e-05	0.000364	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—EP300—ocular cancer	7.48e-05	0.000361	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—HRAS—ocular cancer	7.44e-05	0.000359	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—AKT1—ocular cancer	7.36e-05	0.000355	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—GNAQ—ocular cancer	7.3e-05	0.000352	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CDKN1A—ocular cancer	7.3e-05	0.000352	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—TGFB1—ocular cancer	7.28e-05	0.000351	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—GNAQ—ocular cancer	7.28e-05	0.000351	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—GNA11—ocular cancer	7.27e-05	0.000351	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CDKN1B—ocular cancer	7.17e-05	0.000346	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	7.13e-05	0.000344	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—GNA11—ocular cancer	7.1e-05	0.000343	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CDKN1A—ocular cancer	7.01e-05	0.000338	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GNA11—ocular cancer	6.99e-05	0.000337	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—EP300—ocular cancer	6.95e-05	0.000335	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CDKN1B—ocular cancer	6.89e-05	0.000332	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—GNAQ—ocular cancer	6.76e-05	0.000326	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—AKT1—ocular cancer	6.67e-05	0.000322	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CDKN1A—ocular cancer	6.62e-05	0.000319	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—GNAQ—ocular cancer	6.6e-05	0.000318	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—AKT1—ocular cancer	6.57e-05	0.000317	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HDAC1—ocular cancer	6.56e-05	0.000317	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GNAQ—ocular cancer	6.5e-05	0.000313	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CDKN1A—ocular cancer	6.36e-05	0.000307	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—EP300—ocular cancer	6.3e-05	0.000304	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—AKT1—ocular cancer	6.29e-05	0.000303	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	6.02e-05	0.00029	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HDAC1—ocular cancer	5.95e-05	0.000287	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	5.89e-05	0.000284	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CDKN2B—ocular cancer	5.88e-05	0.000284	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—HRAS—ocular cancer	5.73e-05	0.000277	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HDAC1—ocular cancer	5.55e-05	0.000268	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GNA11—ocular cancer	5.55e-05	0.000268	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—AKT1—ocular cancer	5.5e-05	0.000265	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—E2F1—ocular cancer	5.4e-05	0.00026	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—EP300—ocular cancer	5.38e-05	0.00026	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CDKN2B—ocular cancer	5.33e-05	0.000257	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	5.24e-05	0.000253	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GNA11—ocular cancer	5.21e-05	0.000251	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GNAQ—ocular cancer	5.16e-05	0.000249	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—AKT1—ocular cancer	5.06e-05	0.000244	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—MDM2—ocular cancer	5.05e-05	0.000243	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CDKN2B—ocular cancer	4.98e-05	0.00024	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—E2F1—ocular cancer	4.9e-05	0.000236	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GNAQ—ocular cancer	4.84e-05	0.000234	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—HRAS—ocular cancer	4.75e-05	0.000229	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MDM2—ocular cancer	4.66e-05	0.000225	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CDKN1B—ocular cancer	4.61e-05	0.000222	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—AKT1—ocular cancer	4.59e-05	0.000221	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—MDM2—ocular cancer	4.58e-05	0.000221	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—HRAS—ocular cancer	4.57e-05	0.00022	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—HRAS—ocular cancer	4.31e-05	0.000208	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CDKN1B—ocular cancer	4.25e-05	0.000205	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CDKN1A—ocular cancer	4.25e-05	0.000205	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—AKT1—ocular cancer	4.2e-05	0.000203	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CDKN1B—ocular cancer	4.18e-05	0.000202	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	4.16e-05	0.000201	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HRAS—ocular cancer	4.14e-05	0.0002	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—EP300—ocular cancer	4.05e-05	0.000195	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—AKT1—ocular cancer	4.03e-05	0.000194	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CDKN1A—ocular cancer	3.93e-05	0.000189	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CDKN1A—ocular cancer	3.86e-05	0.000186	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—AKT1—ocular cancer	3.81e-05	0.000184	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—EP300—ocular cancer	3.74e-05	0.00018	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—MYC—ocular cancer	3.73e-05	0.00018	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—EP300—ocular cancer	3.67e-05	0.000177	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—AKT1—ocular cancer	3.66e-05	0.000176	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—EP300—ocular cancer	3.33e-05	0.000161	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MDM2—ocular cancer	3.26e-05	0.000157	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MYC—ocular cancer	3.26e-05	0.000157	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—AKT1—ocular cancer	3.25e-05	0.000157	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—TGFB1—ocular cancer	3.25e-05	0.000157	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CDKN1B—ocular cancer	2.98e-05	0.000144	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MDM2—ocular cancer	2.96e-05	0.000143	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCND1—ocular cancer	2.84e-05	0.000137	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HRAS—ocular cancer	2.77e-05	0.000134	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MDM2—ocular cancer	2.76e-05	0.000133	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CDKN1A—ocular cancer	2.75e-05	0.000133	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CDKN1B—ocular cancer	2.7e-05	0.00013	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—EP300—ocular cancer	2.62e-05	0.000127	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—EP300—ocular cancer	2.62e-05	0.000126	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—AKT1—ocular cancer	2.59e-05	0.000125	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCND1—ocular cancer	2.58e-05	0.000124	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—HRAS—ocular cancer	2.56e-05	0.000123	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CDKN1B—ocular cancer	2.52e-05	0.000122	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HRAS—ocular cancer	2.51e-05	0.000121	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CDKN1A—ocular cancer	2.49e-05	0.00012	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—AKT1—ocular cancer	2.45e-05	0.000118	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—EP300—ocular cancer	2.43e-05	0.000117	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EP300—ocular cancer	2.37e-05	0.000114	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—EP300—ocular cancer	2.33e-05	0.000113	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CDKN1A—ocular cancer	2.33e-05	0.000112	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MYC—ocular cancer	2.28e-05	0.00011	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TGFB1—ocular cancer	2.27e-05	0.00011	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—AKT1—ocular cancer	2.26e-05	0.000109	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—AKT1—ocular cancer	2.22e-05	0.000107	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—EP300—ocular cancer	2.21e-05	0.000107	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MYC—ocular cancer	2.07e-05	9.97e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TGFB1—ocular cancer	2.06e-05	9.95e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—AKT1—ocular cancer	2.01e-05	9.71e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MYC—ocular cancer	1.93e-05	9.3e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TGFB1—ocular cancer	1.92e-05	9.28e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TP53—ocular cancer	1.87e-05	9.03e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—EP300—ocular cancer	1.85e-05	8.94e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HRAS—ocular cancer	1.79e-05	8.64e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—EP300—ocular cancer	1.74e-05	8.4e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TP53—ocular cancer	1.7e-05	8.19e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HRAS—ocular cancer	1.62e-05	7.83e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—AKT1—ocular cancer	1.59e-05	7.65e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—AKT1—ocular cancer	1.58e-05	7.63e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HRAS—ocular cancer	1.51e-05	7.31e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—AKT1—ocular cancer	1.47e-05	7.08e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—AKT1—ocular cancer	1.43e-05	6.91e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—AKT1—ocular cancer	1.41e-05	6.81e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—AKT1—ocular cancer	1.34e-05	6.45e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—AKT1—ocular cancer	1.12e-05	5.4e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—AKT1—ocular cancer	1.05e-05	5.08e-05	CbGpPWpGaD
